Accord Healthcare’s Post

We were honored to host H.E. Yossi Levi Sfari, the Ambassador of the State of Israel to Bulgaria, and Mr. Parvan Dangov, the Mayor of Dupnitsa, at our Teva plant in Dupnitsa, which proudly celebrates its 70th anniversary this year. During the visit, the Ambassador and Mayor were introduced to the significant economic impact Teva has on Bulgaria, our innovative production practices, and our strong commitment to environmental sustainability. The discussions also touched on the challenges faced by the pharmaceutical industry. Together with Mr. Robert Kuzela, Director of the Dupnitsa plant, and Mr. Nikolay Hadzhidonchev, Executive Director of Teva's sales divisions in Bulgaria and Greece, the visitors explored our new production facility, which represents a USD 42 million investment. This expansion will increase our production capacity and create new jobs, further supporting the local community in Dupnitsa and the surrounding region. It was emphasized the significant contribution of Teva's investments in Dupnitsa, Troyan, and Sofia to Bulgaria's economic development, providing stable employment for nearly 2,000 people. The Dupnitsa plant, equipped with state-of-the-art technology, produces high-quality medicines for over 70 markets worldwide. Teva is positioning Bulgaria as an important part of its corporate production network. We are proud to be at the forefront of these developments, driving innovation, and contributing to Bulgaria's growth and prosperity. #TevaBulgaria #70YearsOfExcellence #IsraelBulgariaRelations #Pharmaceuticals #Innovation #EconomicImpact #CorporateSocialResponsibility #Healthcare

Venus is proud to announce the Marketing Authorization of its products across multiple countries, marking another milestone in our global journey. In the Philippines, Bendamustine and Paclitaxel have been approved. Morocco now welcomes Carbol, while Ukraine has granted approval for Carboplatin. In Turkmenistan, Ceftriaxone has received authorization, and Paraguay adds Gemcitabine to its healthcare offerings. In Mexico, Cisplatin has been approved, and Guinea now features Imi-Lux, Para-Lux, and Ceftri Lux. These approvals reflect Venus’s commitment to delivering quality healthcare solutions and expanding access to essential medicines worldwide. With each new market, we continue to grow our global presence, ensuring that more patients can benefit from our innovative treatments. We look forward to further expanding our reach and making a positive impact on global healthcare. News coverage by Ms Maneesha Bhatt, reporter at Venus Pulse #VenusPharma #MarketingAuthorization #GlobalHealthcare #HealthcareInnovation #VenusProducts #GlobalExpansion #VenusPulse #VenusRemedies

Teva Bulgaria We were honored to host H.E. Yossi Levi Sfari, the Ambassador of the State of Israel to Bulgaria, and Mr. Parvan Dangov, the Mayor of Dupnitsa, at our Teva plant in Dupnitsa, which proudly celebrates its 70th anniversary this year. During the visit, the Ambassador and Mayor were introduced to the significant economic impact Teva has on Bulgaria, our innovative production practices, and our strong commitment to environmental sustainability. The discussions also touched on the challenges faced by the pharmaceutical industry. Together with Mr. Robert Kuzela, Director of the Dupnitsa plant, and Mr. Nikolay Hadzhidonchev, Executive Director of Teva's sales divisions in Bulgaria and Greece, the visitors explored our new production facility, which represents a USD 42 million investment. This expansion will increase our production capacity and create new jobs, further supporting the local community in Dupnitsa and the surrounding region. It was emphasized the significant contribution of Teva's investments in Dupnitsa, Troyan, and Sofia to Bulgaria's economic development, providing stable employment for nearly 2,000 people. The Dupnitsa plant, equipped with state-of-the-art technology, produces high-quality medicines for over 70 markets worldwide. Teva is positioning Bulgaria as an important part of its corporate production network. We are proud to be at the forefront of these developments, driving innovation, and contributing to Bulgaria's growth and prosperity. #TevaBulgaria #70YearsOfExcellence #IsraelBulgariaRelations #Pharmaceuticals #Innovation #EconomicImpact #CorporateSocialResponsibility #Healthcare

ReNerve Limited (ASX:RNV) is pleased to announce that it has signed an exclusive distribution partnership with Union MediScience B.S.C based in Bahrain. The agreement covers five countries across the Middle East: Bahrain, Kuwait, UAE/Dubai, Qatar and Saudi Arabia. Read more: https://lnkd.in/gh3rGQvy $RNV Julian Chick

Experience Unmatched Growth Opportunities at #Pharma_Europe 2025!Step into a world of unparalleled growth and #opportunity at 35th Annual European Pharma Congress Set to take place on March 10-11, 2025 Rome, Italy. This premier event offers a #dynamic platform for professional advancement and industry #innovation. Here’s why you should seize this #opportunity. ·        Expand Your Knowledge Base ·        Enhance Your Skillset ·        Enhance Your Professional Profile ·        Join a Global Community #PharmaEurope2025 #CallForProposals #IndustryExperts #ProfessionalDevelopment #NetworkingOpportunities #SubmitYourProposal #SuccessStories

October 2024 marks the opening of our offices in Europe! This equips us to perform all activities in EU which require a local presence, and hence makes us an ideal service provider for European Markets! #metina #metinapharmconsulting #metinaeurope #pharmaconsulting #pharmaceuticalconsulting #globalregulatoryconsulting

MoUs worth $250 million were signed at the China-Pakistan B2B matchmaking conference in the medical equipment and surgical instrument sector held Friday in Beijing. Silk Road Assistance Industrial Internet Platform, a provider of advisory services for companies to do cross-border businesses, entered into agreements respectively with Pakistan’s dental and surgical instrument manufacturer Sawuat, and Chinese pharmaceutical company UPH Biopharma to steer more Chinese companies to engage in trade and set up joint ventures in Pakistan in the medical instrument sector. China Pakistan Medical Association reached an agreement with a technology company based in Hangzhou, China. The association is working to build a China-Pakistan friendship hospital and a joint medical technology park in Pakistan. This event marks the conclusion of the first series of seven B2B events held since Pakistani PM's visit to China last June. It is announced that another seven roadshows are in pipeline and expected to roll out from next month. #MoU #Pakistan #China #Investment

The pharmaceutical industry in Moldova is evolving at a remarkable pace, with companies and investors taking notice of the country’s favorable business environment and strategic advantages. This growth reflects Moldova’s commitment to developing both the pharmaceutical industry and medical tourism sectors. Here are some key insights about the rapid development of these sectors: 💊 Pharmaceutical Growth: Moldova’s pharmaceutical market grew by 14.5% in 2023, and it continues to expand, offering immense opportunities for investment and collaboration. 📦 Export Expansion: Pharmaceutical exports from Moldova have increased by 225% over the past five years, opening doors for Moldovan-made products in both European and international markets. 💼 Investment-Friendly Environment: With 0% tax on retained earnings and 8% VAT for pharmaceuticals, Moldova offers one of the most favorable tax regimes for businesses in the region. 🇲🇩 Strategic Location: Moldova’s 47 free trade agreements provide access to over 1 billion potential customers across the globe, making it a prime location for pharmaceutical and medical tourism investments. The Pharmaceutical Industry & Medical Tourism Forum 2024 is a crucial event that will highlight Moldova’s growing role as a key player in these sectors! To register for the Forum, visit the link: https://lnkd.in/dXXQUtMj Join us and be part of the most important healthcare event of 2024! Event details: 📅 Date: September 19, 2024 📍 Location: Urban Business Center, Chișinău, 115/1 Ștefan cel Mare Street ⏳ Time: Starting at 10:00 AM The Pharmaceutical Industry & Medical Tourism Forum 2024 is a collaborative initiative supported by Invest Moldova, the Ministry of Health, the National Agency of Tourism, and various private clinics and hospitals across the country. Together, we are building Moldova’s future as a hub for pharmaceutical innovation and medical tourism. #PharmaTourism2024 #InvestInMoldova #GlobalHealthcare #PharmaInnovation #MedicalTourism #MoldovaBusinessWeek

The reality of medicines sales - mysticism and mystery or rather strict rules and control... 🧐 Tamro Estonia's CEO Tanel Kuusmann, in response to recent media coverage, shared his vision of the Estonian pharmaceutical market and related matters in the Estonian newspaper Maaleht last week. With over 30 years of experience, Tamro is responsible for the availability of every third medicine package in Estonia. We are committed to ensuring that pharmacies and hospitals are well-stocked, compliant and that the entire supply chain works efficiently for everyone. Continuing to make piece by piece changes without analysis is detrimental to the overall performance of the pharmaceutical sector and will ultimately jeopardise long-term sustainability. Pharmacies are accessible to people, there is a large selection of medicines and health products, the prices of medicines are kept under state control with the help of the health fund. Want to learn more about where the mystery is and where it isn't? 🌟 Read the full article in Estonian here - https://lnkd.in/gCQyfhr8 #tamro #management #pharmaceuticalsales

MoUs worth $250 million were signed at the China-Pakistan B2B matchmaking conference in the medical equipment and surgical instrument sector held Friday in Beijing. Silk Road Assistance Industrial Internet Platform, a provider of advisory services for companies to do cross-border businesses, entered into agreements respectively with Pakistan’s dental and surgical instrument manufacturer Sawuat, and Chinese pharmaceutical company UPH Biopharma to steer more Chinese companies to engage in trade and set up joint ventures in Pakistan in the medical instrument sector. China Pakistan Medical Association reached an agreement with a technology company based in Hangzhou, China. The association is working to build a China-Pakistan friendship hospital and a joint medical technology park in Pakistan. This event marks the conclusion of the first series of seven B2B events held since Pakistani PM's visit to China last June. It is announced that another seven roadshows are in pipeline and expected to roll out from next month. #MoU #Pakistan #China #Investment